In this project, investigators are looking at the impact of air pollution in Chicago on racial disparities in biomarkers of cardiometabolic risk.
Overview
Dr. Brisa Aschebrook-Kilfoy is leading a CACHET funded pilot evaluating biomarkers of cardiometabolic disease and air pollution using a subset of existing COMPASS samples, existing ambient exposure data for Chicago, and a combination of newly collected and existing indoor air pollution data collected in COMPASS participant homes.
Significance
Given the plausible biologic mechanisms and the local environmental conditions, an assessment of air pollution and associated health outcomes in highly polluted Chicago communities in comparison to participants from lower exposure communities presents a robust scientific opportunity with potential local implications for environmental justice
Leadership
Dr. Brisa Aschebrook-Kilfoy is a chronic disease and environmental epidemiologist whose research focus is to elucidate the role of environmental, molecular, and genetic factors in the development of cancer and chronic disease in population studies.
She serves as the scientific director for multiple cohort studies in the IPPH and oversees a large research staff. She also co-directs a recruitment core and an integrated health sciences core with expertise in environmental monitoring in Chicago.
